TABLE 2.
Malignancy type | N = 4305 | ||
---|---|---|---|
N | % a | % b | |
AIDS‐defining cancers | 2432 | (49.5%) | (8.7%) |
Non‐Hodgkin lymphoma | 1808 | (36.8%) | (6.4%) |
Kaposi sarcoma | 701 | (14.3%) | (2.5%) |
Burkitt lymphoma | 116 | (2.4%) | (0.4%) |
Cervix uteri | 66 | (1.3%) | (0.2%) |
Non‐AIDS‐defining cancers | 2485 | (50.5%) | (8.8%) |
Bronchus and lung | 303 | (6.2%) | (1.1%) |
Liver and intrahepatic bile ducts | 277 | (5.6%) | (1.0%) |
Stomach | 228 | (4.6%) | (0.8%) |
Malignant neoplasm, without specification of site | 183 | (3.7%) | (0.7%) |
Secondary malignant neoplasm of bone and bone marrow | 140 | (2.8%) | (0.5%) |
Secondary malignant neoplasm of brain and cerebral meninges | 100 | (2.0%) | (0.4%) |
Multiple myeloma | 98 | (2.0%) | (0.3%) |
Rectosigmoid junction and rectum | 94 | (1.9%) | (0.3%) |
Secondary malignant neoplasm of lung | 86 | (1.7%) | (0.3%) |
Sigmoid colon | 52 | (1.1%) | (0.2%) |
Oesophagus | 47 | (1.0%) | (0.2%) |
Breast | 44 | (0.9%) | (0.2%) |
Acute myeloblastic leukaemia (AML) | 39 | (0.8%) | (0.1%) |
Skin of trunk | 28 | (0.6%) | (0.1%) |
N = 4305 people living with HIV (PLWH) with malignancy; PLWH may have more than one type of malignancy.
% among 4917 malignancies.
% among 28 089 total PLWH cohort.